KCNC1 and cardiovascular disorder: Altogether, the discovery of these KChIP ligands has improved our knowledge of the interaction between KV4 and KChIPs and has paved the way for future pharmaceutical development for the treatment of neurodegenerative and cardiovascular diseases involving KV4/KChIPs.